Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612

₹243.34

up-down-arrow-5.46 (-2.19%)

As on 31-Aug-2026 15:31IST

Market cap

info icon

₹2,258 Cr

Revenue (TTM)

info icon

₹1,873 Cr

P/E Ratio

info icon

401

P/B Ratio

info icon

2.3

Div. Yield

info icon

0.1 %

Value Research Rating

Quality Score fund-quick-summary-circle

Quality Score1/10

Growth Score fund-quick-summary-circle

Growth Score6/10

Valuation Score fund-quick-summary-circle

Valuation Score2/10

Momentum Score fund-quick-summary-circle

Momentum Score7/10

Indoco Remedies Share Price

Compare

High: Low: Return:

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 240.80 High: 251.40

52 Week Range

Low: 162.19 High: 332.20

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹6 Cr

  • ROEROE information

    -10.1 %

  • ROCEROCE information

    0.8 %

  • Industry P/EIndustry P/E information

    55.07

  • EV/EBITDAEV/EBITDA information

    19.3

  • Debt to EquityDebt to Equity information

    1.1

  • Book ValueBook Value information

    ₹108.2

  • EPSEPS information

    ₹-7.9

  • Face valueFace value information

    2

  • Shares outstandingShares outstanding information

    92,303,605

10 Years Aggregate

CFO

₹1,343.75 Cr

EBITDA

₹1,787.04 Cr

Net Profit

₹449.90 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Indoco Remedies
3.7 12.3 16.1 -8.7 -8.6 -12.2 -2.7
BSE Healthcare
18.7 1.7 10.2 18.2 22.8 14.5 12.3
As on 31-Aug-2026
Company
2025
2024
2023
2022
2021
2020
2019
Indoco Remedies
-29.4 -14.9 -2.8 -10.5 49.3 61.3 -12.1
BSE Small Cap
-6.6 29.0 47.5 -1.8 62.8 32.1 -6.8
BSE Healthcare
-3.3 43.1 37.0 -12.1 20.9 61.4 -3.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Indoco Remedies
243.3 2,257.8 1,873.1 3.1 1.8 -7.6 401 2.3
1,405.7 17,299.7 2,590.4 603.0 29.3 19.6 28.7 5.0
578.8 10,986.5 885.7 234.9 27.8 18 46.8 4.9
1,446.1 15,274.0 1,108.4 270.2 28.3 14.5 55.5 7.4
1,855.3 35,075.4 9,683.5 1,019.0 15.7 21.3 34.7 6.7
23,010.0 29,429.3 2,371.8 497.8 28.0 28.5 59.1 14.6
970.9 5,765.5 942.6 9.9 0.3 1.2 665.3 4.4
1,432.8 6,677.8 691.7 130.8 24.5 14.5 52.8 6.9
1,209.7 13,670.7 675.6 183.6 32.2 22.7 74.9 14.8
392.1 10,791.1 8.8 -352.4 -4,228.0 -80.8 -- 19.4

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

About Indoco Remedies

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients,...  urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, anti-inflammatory drugs, etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, extractables and leachables studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom chemical synthesis of molecules and intermediates; process chemistry research and development; non-infringing process designing and scale up; and analytical method development, validation, impurity characterization, and polymorphic studies, solutions, as well as intellectual property management. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India. 

  • Incorporated

    1947

  • Chairman

    Suresh G Kare

  • Managing Director

    Aditi Panandikar

  • Headquarters

    Mumbai, Maharashtra

  • Website

    www.indoco.com

FAQs for Indoco Remedies

The share price of Indoco Remedies Ltd is ₹243.34 (NSE) and ₹243.35 (BSE) as of 31-Aug-2026 15:31 IST. Indoco Remedies Ltd has given a return of -8.65% in the last 3 years.

The P/E ratio of Indoco Remedies Ltd is 401.02 times as on 31-Aug-2026, a 628 premium to its peers’ median range of 55.07 times.
The P/B ratio of Indoco Remedies Ltd is 2.26 times as on 31-Aug-2026, a 50 discount to its peers’ median range of 4.48 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2026
0.00
1.63
2025
0.00
2.12
2024
30.76
2.74
2023
21.09
2.92
2022
22.42
3.84

The 52-week high and low of Indoco Remedies Ltd are Rs 332.20 and Rs 162.19 as of 31-Aug-2026.

Indoco Remedies Ltd has a market capitalisation of ₹ 2,258 Cr as on 31-Aug-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Indoco Remedies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...